These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6798900)

  • 41. Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy.
    Rogala B; Glück J
    J Investig Allergol Clin Immunol; 1999; 9(3):183-9. PubMed ID: 10412681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blocking antibodies in allergic rhinitis.
    Hlasivcová V
    Acta Allergol; 1969 Sep; 24(3):194-201. PubMed ID: 5395877
    [No Abstract]   [Full Text] [Related]  

  • 43. Glutaraldehyde-pollen-tyrosine: clinical and immunological studies.
    Johansson SG; Miller AC; Mullan N; Overell BG; Tees EC; Wheeler A
    Clin Allergy; 1974 Sep; 4(3):255-63. PubMed ID: 4214633
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
    Alvarez-Cuesta E; Aragoneses-Gilsanz E; Martín-Garcia C; Berges-Gimeno P; Gonzalez-Mancebo E; Cuesta-Herranz J
    Clin Exp Allergy; 2005 May; 35(5):572-8. PubMed ID: 15898977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sublingual immunotherapy.
    Frew AJ
    N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract]   [Full Text] [Related]  

  • 47. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE; Andri G; Dama AR; Falagiani P; Andri L
    Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen].
    MMW Fortschr Med; 2004 Mar; 146(11):58. PubMed ID: 15152778
    [No Abstract]   [Full Text] [Related]  

  • 49. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Specific desensitization in hay fever with commercial allergen extracts].
    Lowewe G
    Z Arztl Fortbild (Jena); 1966 Nov; 60(21):1211-3. PubMed ID: 5990876
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 52. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific immunotherapy with purified grass pollen extracts.
    Osterballe O
    Dan Med Bull; 1984 Jun; 31(3):207-26. PubMed ID: 6744952
    [No Abstract]   [Full Text] [Related]  

  • 54. [Specific brief immunotherapy receives MMW Drug Prize 2004. Four pricks expel pollen allergy].
    Füessl HS
    MMW Fortschr Med; 2004 Sep; 146(37):13. PubMed ID: 15887695
    [No Abstract]   [Full Text] [Related]  

  • 55. Monitoring of different forms of immunotherapy by measuring of grass pollen specific "blocking antibodies".
    Maasch HJ; Puttonen E
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):91-100. PubMed ID: 6625591
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hyposensitization with tyrosine-allergoids (author's transl)].
    Reinert M; Biro G
    Prax Klin Pneumol; 1981 Feb; 35(2):71-5. PubMed ID: 7208409
    [No Abstract]   [Full Text] [Related]  

  • 57. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of grass pollen-specific immunotherapy among grass pollen allergic rhinitis in the general population.
    Linneberg A; Bødtger U
    Allergy; 2007 Jul; 62(7):825-6. PubMed ID: 17573735
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.